Tan CK - Search Results

1

Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.

Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB, Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, Chang JPE, Tan CK, Lee CGL. Jin Y, et al. Among authors: tan hh, tan ck. Sci Rep. 2019 Jul 18;9(1):10464. doi: 10.1038/s41598-019-46872-8. Sci Rep. 2019. PMID: 31320713 Free PMC article.

2

Blood aflatoxin levels in patients with hepatocellular carcinoma in Singapore.

Tan CK, Lo DS, Law NM, Ng HS, Chao TC. Tan CK, et al. Singapore Med J. 1995 Dec;36(6):612-4. Singapore Med J. 1995. PMID: 8781632

3

Screening for hepatocellular carcinoma (HCC) in a hepatitis B carrier.

Tan CK, Ng HS. Tan CK, et al. Singapore Med J. 1998 May;39(5):229-30. Singapore Med J. 1998. PMID: 9713232 No abstract available.

4

Use of tamoxifen in hepatocellular carcinoma: a review and paradigm shift.

Tan CK, Chow PK, Findlay M, Wong C, Machin D. Tan CK, et al. J Gastroenterol Hepatol. 2000 Jul;15(7):725-9. doi: 10.1046/j.1440-1746.2000.02235.x. J Gastroenterol Hepatol. 2000. PMID: 10937676 Review.

5

Liver transplantation in hepatocellular carcinoma.

Wai CT, Lo SK, Lee KH, Tan CK, Isacc J, Prabhakaran K, Lim SG, Tan KC. Wai CT, et al. Among authors: tan ck, tan kc. Transplant Proc. 2000 Nov;32(7):2173. doi: 10.1016/s0041-1345(00)01621-3. Transplant Proc. 2000. PMID: 11120119 No abstract available.

6

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.

Chow PK, Tai BC, Tan CK, Machin D, Win KM, Johnson PJ, Soo KC; Asian-Pacific Hepatocellular Carcinoma Trials Group. Chow PK, et al. Among authors: tan ck. Hepatology. 2002 Nov;36(5):1221-6. doi: 10.1053/jhep.2002.36824. Hepatology. 2002. PMID: 12395333 Clinical Trial.

7

Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation.

Tan CK, Law NM, Ng HS, Machin D. Tan CK, et al. J Clin Oncol. 2003 Jun 15;21(12):2294-8. doi: 10.1200/JCO.2003.03.151. J Clin Oncol. 2003. PMID: 12805329

8

Phase II trial of gemcitabine in combination with cisplatin in inoperable or advanced hepatocellular carcinoma.

Chia WK, Ong S, Toh HC, Hee SW, Choo SP, Poon DY, Tay MH, Tan CK, Koo WH, Foo KF. Chia WK, et al. Among authors: tan ck. Ann Acad Med Singap. 2008 Jul;37(7):554-8. Ann Acad Med Singap. 2008. PMID: 18695766 Free article. Clinical Trial.

9

Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.

Chang PE, Ong WC, Lui HF, Tan CK. Chang PE, et al. Among authors: tan ck. J Gastroenterol. 2008;43(11):881-8. doi: 10.1007/s00535-008-2238-x. Epub 2008 Nov 18. J Gastroenterol. 2008. PMID: 19012042

10

Combined heart-liver transplantation with extended cardiopulmonary bypass.

Marriott AJ, Hwang NC, Lai FO, Tan CK, Tan YM, Lim CH, Boey SK, Tay SM, Cheow PC, Lim YP, Chan T, Loh K, Kwok B, Chung A, Sivathasan C. Marriott AJ, et al. Among authors: tan ym, tan ck. Singapore Med J. 2011 Mar;52(3):e48-51. Singapore Med J. 2011. PMID: 21451915 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page